Antipyrine

Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose

R. L. Chang, A. W. Wood, W. R. Dixon, A. H. Conney, Karl Anderson, J. Eiseman, A. P. Alvares

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

A simple and sensitive radioimmunoassay has been developed for the determination of antipyrine levels in plasma and saliva of man. Antiserum to antipyrine was obtained from rabbits immunized with an immunogen prepared by covalently coupling N-(4-antipyrinyl)-succinamic acid to bovine serum albumin (BSA). The radioimmunoassay can detect antipyrine levels as low as 10 nglml of plasma or saliva, using a 0.1-ml sample. This contrasts with the sensitivity of a commonly used spectrophotometric method that can measure about 4,000 nglml using a 2-ml plasma sample. Agreement between the radioimmunoassay and spectrophotometric assay of antipyrine was excellent for plasma (r = 0.98) and saliva (r = 0.97) when samples were analyzed from 6 subjects receiving 18 mg/kg of antipyrine. The correlation between plasma and saliva antipyrine half-lives using the radioimmunoassay and an 18 mg/kg dose of antipyrine was r = 0.90 (p < 0.005). After a dose of 1.8 mg/kg of antipyrine, the drug disappeared monoexponentially from plasma and saliva for at least 51 hr, and the correlation between plasma half-life and saliva half-life was r = 0.97 (p < 0.001) in the 6 subjects. Excellent agreement was also observed between half-lives after the high and low doses of antipyrine (r = 0.99, p < 0.001 for plasma and r = 0.98, p < 0.001 for saliva).

Original languageEnglish (US)
Pages (from-to)219-226
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume20
Issue number2
StatePublished - Aug 1976
Externally publishedYes

Fingerprint

Antipyrine
Saliva
Radioimmunoassay
Half-Life
Contrast Sensitivity
Bovine Serum Albumin
Immune Sera
Rabbits
Acids

ASJC Scopus subject areas

  • Pharmacology

Cite this

Chang, R. L., Wood, A. W., Dixon, W. R., Conney, A. H., Anderson, K., Eiseman, J., & Alvares, A. P. (1976). Antipyrine: Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. Clinical Pharmacology and Therapeutics, 20(2), 219-226.

Antipyrine : Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. / Chang, R. L.; Wood, A. W.; Dixon, W. R.; Conney, A. H.; Anderson, Karl; Eiseman, J.; Alvares, A. P.

In: Clinical Pharmacology and Therapeutics, Vol. 20, No. 2, 08.1976, p. 219-226.

Research output: Contribution to journalArticle

Chang, RL, Wood, AW, Dixon, WR, Conney, AH, Anderson, K, Eiseman, J & Alvares, AP 1976, 'Antipyrine: Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose', Clinical Pharmacology and Therapeutics, vol. 20, no. 2, pp. 219-226.
Chang, R. L. ; Wood, A. W. ; Dixon, W. R. ; Conney, A. H. ; Anderson, Karl ; Eiseman, J. ; Alvares, A. P. / Antipyrine : Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. In: Clinical Pharmacology and Therapeutics. 1976 ; Vol. 20, No. 2. pp. 219-226.
@article{9dab7f05c0d84b7e926d201c352226b7,
title = "Antipyrine: Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose",
abstract = "A simple and sensitive radioimmunoassay has been developed for the determination of antipyrine levels in plasma and saliva of man. Antiserum to antipyrine was obtained from rabbits immunized with an immunogen prepared by covalently coupling N-(4-antipyrinyl)-succinamic acid to bovine serum albumin (BSA). The radioimmunoassay can detect antipyrine levels as low as 10 nglml of plasma or saliva, using a 0.1-ml sample. This contrasts with the sensitivity of a commonly used spectrophotometric method that can measure about 4,000 nglml using a 2-ml plasma sample. Agreement between the radioimmunoassay and spectrophotometric assay of antipyrine was excellent for plasma (r = 0.98) and saliva (r = 0.97) when samples were analyzed from 6 subjects receiving 18 mg/kg of antipyrine. The correlation between plasma and saliva antipyrine half-lives using the radioimmunoassay and an 18 mg/kg dose of antipyrine was r = 0.90 (p < 0.005). After a dose of 1.8 mg/kg of antipyrine, the drug disappeared monoexponentially from plasma and saliva for at least 51 hr, and the correlation between plasma half-life and saliva half-life was r = 0.97 (p < 0.001) in the 6 subjects. Excellent agreement was also observed between half-lives after the high and low doses of antipyrine (r = 0.99, p < 0.001 for plasma and r = 0.98, p < 0.001 for saliva).",
author = "Chang, {R. L.} and Wood, {A. W.} and Dixon, {W. R.} and Conney, {A. H.} and Karl Anderson and J. Eiseman and Alvares, {A. P.}",
year = "1976",
month = "8",
language = "English (US)",
volume = "20",
pages = "219--226",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Antipyrine

T2 - Radioimmunoassay in plasma and saliva following administration of a high dose and a low dose

AU - Chang, R. L.

AU - Wood, A. W.

AU - Dixon, W. R.

AU - Conney, A. H.

AU - Anderson, Karl

AU - Eiseman, J.

AU - Alvares, A. P.

PY - 1976/8

Y1 - 1976/8

N2 - A simple and sensitive radioimmunoassay has been developed for the determination of antipyrine levels in plasma and saliva of man. Antiserum to antipyrine was obtained from rabbits immunized with an immunogen prepared by covalently coupling N-(4-antipyrinyl)-succinamic acid to bovine serum albumin (BSA). The radioimmunoassay can detect antipyrine levels as low as 10 nglml of plasma or saliva, using a 0.1-ml sample. This contrasts with the sensitivity of a commonly used spectrophotometric method that can measure about 4,000 nglml using a 2-ml plasma sample. Agreement between the radioimmunoassay and spectrophotometric assay of antipyrine was excellent for plasma (r = 0.98) and saliva (r = 0.97) when samples were analyzed from 6 subjects receiving 18 mg/kg of antipyrine. The correlation between plasma and saliva antipyrine half-lives using the radioimmunoassay and an 18 mg/kg dose of antipyrine was r = 0.90 (p < 0.005). After a dose of 1.8 mg/kg of antipyrine, the drug disappeared monoexponentially from plasma and saliva for at least 51 hr, and the correlation between plasma half-life and saliva half-life was r = 0.97 (p < 0.001) in the 6 subjects. Excellent agreement was also observed between half-lives after the high and low doses of antipyrine (r = 0.99, p < 0.001 for plasma and r = 0.98, p < 0.001 for saliva).

AB - A simple and sensitive radioimmunoassay has been developed for the determination of antipyrine levels in plasma and saliva of man. Antiserum to antipyrine was obtained from rabbits immunized with an immunogen prepared by covalently coupling N-(4-antipyrinyl)-succinamic acid to bovine serum albumin (BSA). The radioimmunoassay can detect antipyrine levels as low as 10 nglml of plasma or saliva, using a 0.1-ml sample. This contrasts with the sensitivity of a commonly used spectrophotometric method that can measure about 4,000 nglml using a 2-ml plasma sample. Agreement between the radioimmunoassay and spectrophotometric assay of antipyrine was excellent for plasma (r = 0.98) and saliva (r = 0.97) when samples were analyzed from 6 subjects receiving 18 mg/kg of antipyrine. The correlation between plasma and saliva antipyrine half-lives using the radioimmunoassay and an 18 mg/kg dose of antipyrine was r = 0.90 (p < 0.005). After a dose of 1.8 mg/kg of antipyrine, the drug disappeared monoexponentially from plasma and saliva for at least 51 hr, and the correlation between plasma half-life and saliva half-life was r = 0.97 (p < 0.001) in the 6 subjects. Excellent agreement was also observed between half-lives after the high and low doses of antipyrine (r = 0.99, p < 0.001 for plasma and r = 0.98, p < 0.001 for saliva).

UR - http://www.scopus.com/inward/record.url?scp=0017077387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017077387&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 219

EP - 226

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -